LIVER FAILURE
Clinical trials for LIVER FAILURE explained in plain language.
Never miss a new study
Get alerted when new LIVER FAILURE trials appear
Sign up with your email to follow new studies for LIVER FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can stem cells in a blood filter help failing livers?
Disease control Recruiting nowThis early study tests whether adding stem cells to a blood purification machine can safely help adults with liver failure. Ten participants will receive the treatment outside the body, and researchers will track survival, need for a liver transplant, and side effects. The goal i…
Matched conditions: LIVER FAILURE
Phase: PHASE1 • Sponsor: Kebo Zhong • Aim: Disease control
Last updated May 17, 2026 04:18 UTC
-
Diabetes drug shows promise for liver fluid woes
Disease control Recruiting nowThis study tests whether empagliflozin, a diabetes drug, can help people with cirrhosis (liver scarring) and ascites (fluid buildup in the belly) get rid of excess salt and water. About 20 adults on stable diuretic therapy will receive either the drug or a placebo for 14 days. Th…
Matched conditions: LIVER FAILURE
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 17, 2026 04:18 UTC
-
Diabetes drug shows promise for dangerous low sodium
Disease control Recruiting nowThis study tests whether empagliflozin (Jardiance), a drug currently used for diabetes, can safely raise low sodium levels in patients with conditions like SIADH, liver failure, or kidney failure. About 172 adults with chronic low sodium will receive either the drug or a placebo …
Matched conditions: LIVER FAILURE
Phase: PHASE4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
New study seeks right dose for cancer drug in patients with liver issues
Disease control Recruiting nowThis early-phase study aims to find a safe starting dose of the drug sacituzumab govitecan for people with advanced solid tumors who also have moderate liver impairment. About 30 participants will receive the drug to monitor side effects and how the drug moves through the body. T…
Matched conditions: LIVER FAILURE
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Artificial liver device shows promise in early trial for liver failure patients
Disease control Recruiting nowThis study is testing a new bioartificial liver device (CiPS-BAL) in 12 people with liver failure or small-for-size syndrome. The main goal is to see if the device is safe and tolerable, while also checking how it affects liver function and overall health. Participants will recei…
Matched conditions: LIVER FAILURE
Phase: PHASE1, PHASE2 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Gut bacteria cocktail aims to tame liver failure
Disease control Recruiting nowThis early-stage trial tests whether giving a mix of healthy gut bacteria (from donors) to people hospitalized with liver disease is safe and tolerable. The study involves 24 adults with liver failure or cirrhosis who have low levels of certain gut chemicals. Researchers will mon…
Matched conditions: LIVER FAILURE
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New model aims to predict dangerous liver complication after surgery
Knowledge-focused Recruiting nowThis study looks at whether the amount of healthy liver tissue removed during surgery can help predict a serious complication called post-hepatectomy liver failure. Researchers will analyze data from 1600 patients who had liver surgery for cancer. The goal is to create a tool tha…
Matched conditions: LIVER FAILURE
Sponsor: National Natural Science Foundation of China • Aim: Knowledge-focused
Last updated May 17, 2026 04:28 UTC